Skip to main navigation Skip to search Skip to main content

Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020–2021) in 12 Countries of the C-MOR Consortium

  • The C-MOR Consortium
  • University of Nicosia Medical School
  • PlanAdapt
  • University of Perugia
  • University of Limassol
  • Massachusetts Institute of Technology
  • Deakin University
  • Monash University
  • Medical University of Vienna
  • Universidade Federal do Rio de Janeiro
  • Universidade Federal Fluminense
  • Ministry of Health, Cyprus
  • St. George's University of London
  • National Center for Disease Control and Public Health
  • Al Farabi Kazakh National University
  • Kazakh National Medical University
  • Nazarbayev University
  • National Institute of Public Health
  • University of Nicosia

Research output: Contribution to journalArticlepeer-review

Abstract

Background: This study investigated cause-specific mortality rates in 12 countries during the COVID-19 pandemic in 2020 and 2021. Methods: We collected weekly cause-specific mortality data from respiratory disease, pneumonia, cardiovascular disease (CVD) and cancer from national vital statistic databases. We calculated excess mortality for respiratory disease (excluding COVID-19 codes), pneumonia, and CVD in 2020 and 2021 by comparing observed weekly against expected mortality based on historical data (2015–2019), accounting for seasonal trends. We used multilevel regression models to investigate the association between country-level pandemic-related variables and cause-specific mortality. Results: Significant reductions in cumulative mortality from respiratory disease and pneumonia were observed in 2020 and/or 2021, except for Georgia, Northern Ireland, Kazakhstan, and Ukraine, which exhibited excess mortality for one or both causes. Australia, Austria, Cyprus, Georgia, and Northern Ireland experienced excess cumulative CVD mortality in 2020 and/or 2021. Australia, Austria, Brazil, Cyprus, Georgia, Northern Ireland, Scotland and Slovenia, experienced increased crude cumulative cancer mortality during 2020 and/or 2021 compared to previous years. Among pandemic-related variables, reported COVID-19 incidence was negatively associated with increased cancer mortality, excess respiratory, (2020) and pneumonia (2021) mortality, and positively associated with respiratory and CVD mortality (2021). Stringency of control measures were negatively associated with excess respiratory disease, CVD, and increased cancer mortality (2021). Conclusions: This study provides evidence of substantial excess mortality from CVD, and notable reductions in respiratory disease and pneumonia in both years across most countries investigated. Our study also highlights the beneficial impact of stringent control measures in mitigating excess mortality from most causes in 2021.

Original languageEnglish
Pages (from-to)337-348
Number of pages12
JournalJournal of Epidemiology and Global Health
Volume14
Issue number2
DOIs
Publication statusPublished - Jun 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities
  3. SDG 12 - Responsible Consumption and Production
    SDG 12 Responsible Consumption and Production

Keywords

  • Cancer
  • Cardiovascular diseases
  • Cause-specific mortality
  • COVID-19
  • Public health measures
  • Respiratory tract infections

ASJC Scopus subject areas

  • Epidemiology

Fingerprint

Dive into the research topics of 'Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020–2021) in 12 Countries of the C-MOR Consortium'. Together they form a unique fingerprint.

Cite this